Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience

Authors

Geoffrey D. Barnes
Scott Kaatz, Henry Ford HealthFollow
Alexis Lopez
Xiaokui Gu
Jay Kozlowski
Gregory D. Krol, Henry Ford HealthFollow
James B. Froehlich

Recommended Citation

Barnes GD, Kaatz S, Lopez A, Gu X, Kozlowski J, Krol GD, Froehlich JB. Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience. JAMA Cardiol. 2017 Mar 1;2(3):341-343.

Document Type

Article

Publication Date

3-1-2017

Publication Title

JAMA Cardiol

Medical Subject Headings

Anticoagulants; Atrial Fibrillation; Humans; Incidence; Michigan; Quality Improvement; Stroke; Warfarin

PubMed ID

28052153

Volume

2

Issue

3

First Page

341

Last Page

343